Lupin Limited
http://www.lupin.com
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Lupin Limited
Lupin Reaches Quarter-Of-A-Billion Dollar Deal Over Glumetza Antitrust Claims
Lupin has agreed to pay $248m to settle the majority of antitrust claims against the company alleging that it caused and enabled the prolonged delayed launch of generic Glumetza, which subsequently saw a price hike of more than 800% by originator Valeant, now Bausch Health.
TB Alliance-Lupin Deal To Improve Pretomanid Access But India Unlikely To Benefit For Now
While Viatris says it has sufficient capacity to meet current and future demand for tuberculosis drug pretomanid, TB Alliance has signed a non-exclusive license with Lupin. This is the second tie-up with an Indian manufacturer but the local restricted use approval means countries other than India are likely to benefit for now.
Bausch Agrees $300m Glumetza Antitrust Settlement As Lupin Awaits Trial
Bausch Health, which rebranded from Valeant Pharmaceuticals following a list of controversies, has reached a proposed settlement deal worth $300m to resolve claims it paid off ANDA sponsor Lupin to delay generic entry for a generic to its Glumetza brand, paving the way for an extraordinary price hike.
Lupin Strikes Deal For Anti-TB Drug Pretomanid
Lupin and non-profit organization TB Alliance have entered into a partnership for a new therapy for highly drug-resistant tuberculosis, pretomanid, to be distributed in 140 countries and territories.
Company Information
- Industry
- Pharmaceuticals
-
Pharmaceuticals
- Drug Delivery
- Generic Drugs
- Nutraceuticals
- Specialty Pharmaceuticals
-
Drug Delivery
- Controlled Release
- Pulmonary
-
Biotechnology
-
Drug Discovery Tools
-
Molecular Diversity
- Natural Products
-
Molecular Diversity
-
Drug Discovery Tools
- Other Names / Subsidiaries
-
- Generic Health Pty Ltd
- Temmler Pharma GmbH & Co.
- YL Biologics (YLB)
- ZAO Biocom
- Kyowa Pharmaceutical Industry Co., Ltd.
- Southern Cross Pharma Pty Ltd
- Symbiomix Therapeutics, LLC.